Pharmaceutical Regulatory Affairs: Open Access

5^th International Conference and Exhibition on Pharmaceutical Regulatory Affairs

August 03-05, 2015 Orlando, USA

Posters-Accepted Abstracts

• Sharing regulatory data as tools for strengthening health systems in the region of the Americas

  Varley Dias Sousa1, 2 and Damaris Silveira1

  PDF HTML

• Oral drug suspensions: Is in vitro dissolution testing relevant in predicting the in vivo performance?

  Thaís dos Santos Paulino Soares, Jacqueline de Souza, Lorena de Sousa Rosa, Neila Márcia Silva Barcellos and Flávia Dias Marques Marinho

  PDF HTML

• SWOT analysis of the Addis Ababa City administration food, medicine and health care administration and control authority

  Solomon Getnet Meshesha

  PDF HTML

• Regulatory affairs mobile application: Barriers, benefits and implications for patients

  Kamilah Rashid

  PDF HTML

• Cosmetics regulations in Saudi Arabia

  Athanasia Varvaresou1, Kriton Iakovou2, Spyridon Papageorgiou1, Evangelia Protopapa1 and Fotini Mellou1

  PDF HTML

• The flexibilities for the regulatory guidelines for the bio-similars in emerging markets

  Poongothai Ramaswamy

  PDF HTML

• Need for uniform regulatory guidelines for toxicity evaluation of nanomaterials

  Krutika K Sawant and Aditi S Poddar

  PDF HTML

• Development of Vi polysaccharide for typhoid using animal components-free SCDM medium with high yield

  Asokan C and Catherine O A

  PDF HTML

• Serum total protein, albumin and albumin/globulin biomarkers in patients with active pulmonary tuberculosis

  Zainab Manzoor Memon1, Afsheen Mushtaque Shah1, Bikha Ram Devrajani2 and Tasneem Gul Kazi1

  PDF HTML

• The values of quality practices

  Boyd L Summers

  PDF HTML

• Inflammatory role of nucleotide P2Y2 receptor: Vascular hyperpermeability

  Jianjie Wang1, Laurie Erb2, Virginia Huxley2, Gary Weisman2 and Richard Garrad1

  PDF HTML

• The use of real-time polymerase chain reaction (rT-PCR) technologies to screen for the presence of total bacteria in a liquid sample

  Andy Moreno

  PDF HTML

• Evaluation the effect of GABA in the proliferation and migration of fibroblasts in vitro

  Lucimar Filot da Silva Brum, Vani dos Santos Laranjeiraa and Ivana Grivicich

  PDF HTML

• 21st century skills for managing healthcare professionals

  Puthucode N Rajamani

  PDF HTML

• Beyond harmonization: Regulatory innovation for the next generation of drug development

  Greg Koski

  PDF HTML

• Maximizing your impact: How to look, feel and live like a leader

  Debi Silber

  PDF HTML

• Global vaccines regulation: Safety and quality

  Anthia Zammit

  PDF HTML

• Global regulatory best practices: Companion diagnostics

  Abhishek Harde

  PDF HTML

• Brazilian pharmaceutical regulation on productive partnerships for development of priority drugs

  Elizabeth Alves Fernandes

  PDF HTML

• The judicialization of the applications submitted to ANVISA

  Marcio Raposo de Almeida

  PDF HTML

• Key issues with amended CBE-supplementation for ANDA holders

  Martha

  PDF HTML

• Maximizing your impact: How to look, feel and live like a leader

  Debi Silber

  PDF HTML

• Assessing the quality of human research protection programs to improve protection of human subjects participating in clinical trials

  Min-Fu Tsan

  PDF HTML

• Development of functional foods with β glucans from medicinal mushrooms

  Cleanthes Israilides1, Efi Kondyli2, Eleftherios Eleftheriadis2, Vasilis Mavraganis2, Yannis Samelis2, Theodoros Varzakas5, Chrysoula Salamoura5, Lefteris Lahouvaris3, Ken-ichi Ishibashi4 and Naohito Ohno4

  PDF HTML

• Regulatory intelligence to introduce new technologies: Challenges and solutions to speed ANVISA’s registration

  Ana Carolina Paz

  PDF HTML

• Not a “medical device” – Guidance for low risk, general wellness devices

  Frestedt

  PDF HTML

• Investigating problems, applying risk management and creating sustainable solutions

  Paul R Kleindorfer

  PDF HTML

• Regulatory hurdles affecting US companies to register and market dietary supplements in the Middle East Region and what US dietary supplement manufacturers need to understand

  Reshma Castelino

  PDF HTML

• Strengthening regional collaboration among ASEAN regulatory laboratories to ensure quality assurance in pharmaceuticals

  Maria Soledad Lopez Distor

  PDF HTML

• Impact of novel Mexican policies on the healthcare and pharmaceutical landscape: Is the industry ready for the big boom?

  Ricardo Ibarra-Cabrera

  PDF HTML

• Modern approaches to the estimation and improvement of the quality of clinical trials: Analysis of international and Russian experience

  Vladimir Popov

  PDF HTML

• Discovery of novel, potent and low-toxic Angiotension II receptor type 1 (AT1) blockers: Design, synthesis, biological evaluation and molecular docking studies of 6-substituted Aminocarbonyl Benzimidazoles with a chiral

  Zhi-Ming Zhou, Xiao-Feng Hang, Jun Zhang, Li-Ping Hao, Jin-Liang Wang, Wei-Zhe Xue, Wei-Fa Yu, Fan Fei and Wen-Chang Tao

  PDF HTML

• Antibacterial properties of new bacterium isolated from date palm leaves affected by brittle leaf disease

  Mouna Jrad1, Ben Choba Ines1, Ben Bacha Abir1,2, Drira Nourredine1 and Gharsallah Néji1

  PDF HTML

• A novel “priming-boosting” strategy for immune interventions in cervical cancer

  Shujie

  PDF HTML

• Neuroprotective effect of silymarin on diabetic peripheral neuropathy in streptozotocin-induced diabetic rat model

  Mahmoud A S Morsi, Ahmed M Raslan, Amira A M Etman and Wael MY Mohamed

  PDF HTML

• How to market generics and bio-similars in Saudi Arabia

  Shalu Lalichan

  PDF HTML

• Caper: A precious medicinal plant from ancient times

  Eddouks Mohamed, Hebi Morad and Moufid Abderrahmane

  PDF HTML

• Pharmacological properties of Caraway (Carum carvi L.)

  Eddouks Mohamed, Hebi Morad, Moufid Abderrahmane and El Bouhali Bachir

  PDF HTML

• Regulation of stability studies to enhance the efficiency of drug registrations to regulatory authorities

  M Sajjad Khan and Nabila Akhtar

  PDF HTML

• Piperaquine and Lumefantrine resistance in Plasmodium berghei ANKA associated with increased expression of Ca2+/H+ antiporter and glutathione associated enzymes

  Daniel Kiboi1, 2, Beatrice Irungu2, Jennifer Orwa2, Luna Kamau2, Lynette Isabella Ochola-Oyier2, Joseph Ngángá1 and Alexis Nzila3

  PDF HTML

• Potential endocrine disruptors in herbal medicine: A second look at regulatory issues

  Augustine Onyeaghala

  PDF HTML

• Drug regulations in India- A critical analysis

  K V S Sarma

  PDF HTML

• Modern microextraction techniques for drugs of abuse

  Rajeev Jain

  PDF HTML

• Openness in Nigeria’s public pharmaceutical sector as seen from the eyes of the policy makers

  Adeyemi Oluwatosin Dotun

  PDF HTML

• Regulations on export and manufacture of drugs in India

  Preet Mohinder Singh Bedi

  PDF HTML

• Research driven drug act: Need of the day

  R S Thakur

  PDF HTML

• Regulation of stability studies to enhance the efficiency of drug registrations to regulatory authorities

  M Sajjad Khan and Nabila Akhtar

  PDF HTML

• Innovation respecting IPR for lifting millions out communicable and non-communicable diseases

  Tarakanta Jana

  PDF HTML